STAGE IV NON-SMALL CELL LUNG CANCER
Clinical trials for STAGE IV NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IV NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for STAGE IV NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of two drugs—TG4010 (a vaccine that helps the immune system attack cancer) and nivolumab (an immunotherapy that removes cancer's brakes on immune cells)—in 13 people with advanced non-small cell lung cancer who had already tried other treatments. T…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated May 17, 2026 02:19 UTC
-
Experimental combo shows promise against tough cancers
Disease control CompletedThis study tested a combination of two drugs—sEphB4-HSA and pembrolizumab—in 42 people with advanced non-small cell lung cancer or head & neck cancer that had spread or come back. The goal was to see if the combo could shrink tumors better than standard treatments. Participants h…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New drug cocktail shows promise for tough lung cancers
Disease control CompletedThis study tested a combination of two drugs, auranofin and sirolimus, in 29 people with advanced or recurrent lung cancer who had run out of standard treatment options. The goal was to find the best dose and see if the combo could slow cancer growth. The trial focused on safety …
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo therapy shows promise for brain metastases
Disease control CompletedThis early-stage study tested a combination of an immunotherapy drug (pembrolizumab) and precise radiation (stereotactic radiosurgery) in 25 people with melanoma or lung cancer that had spread to the brain. The main goal was to check for serious side effects. The approach aims to…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Radiation boosts immunotherapy in advanced lung cancer trial
Disease control CompletedThis study tested whether adding high-dose radiation to standard immunotherapy can help control advanced non-small cell lung cancer that has spread. 45 adults with stage IV disease who were already on immunotherapy received targeted radiation to their tumors. The goal was to impr…
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New combo therapy tested for hard-to-treat lung cancer
Disease control CompletedThis early-stage study tested a new drug called ONO-7475 combined with the standard drug osimertinib in 78 people with advanced EGFR-mutant non-small cell lung cancer that could not be treated with radiation. The main goal was to check safety and find the right dose. Researchers …
Matched conditions: STAGE IV NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:56 UTC